These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 9317014)
21. Design of a mimotope-peptide based double epitope vaccine against disseminated candidiasis. Xin H; Glee P; Adams A; Mohiuddin F; Eberle K Vaccine; 2019 Apr; 37(18):2430-2438. PubMed ID: 30930005 [TBL] [Abstract][Full Text] [Related]
22. Synthesis of three trisaccharide congeners to investigate frame shifting of β1,2-mannan homo-oligomers in an antibody binding site. Costello C; Bundle DR Carbohydr Res; 2012 Aug; 357():7-15. PubMed ID: 22658565 [TBL] [Abstract][Full Text] [Related]
23. Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence. Torosantucci A; Chiani P; Bromuro C; De Bernardis F; Palma AS; Liu Y; Mignogna G; Maras B; Colone M; Stringaro A; Zamboni S; Feizi T; Cassone A PLoS One; 2009; 4(4):e5392. PubMed ID: 19399183 [TBL] [Abstract][Full Text] [Related]
24. [Cytologic analysis of the expression of an epitope carried by glycoproteins excreted by Candida albicans]. Cailliez JC; Poulain D Ann Inst Pasteur Microbiol; 1988; 139(2):171-88. PubMed ID: 2457385 [TBL] [Abstract][Full Text] [Related]
25. Tissue invasiveness and non-acidic pH in human candidiasis correlate with "in vivo" expression by Candida albicans of the carbohydrate epitope recognised by new monoclonal antibody 1H4. Monteagudo C; Viudes A; Lazzell A; Martinez JP; Lopez-Ribot JL J Clin Pathol; 2004 Jun; 57(6):598-603. PubMed ID: 15166263 [TBL] [Abstract][Full Text] [Related]
26. The Candida albicans phosphomannan complex in Candida-host interactions. Cutler JE Res Immunol; 1998; 149(4-5):299-308; discussion 507-9. PubMed ID: 9720948 [No Abstract] [Full Text] [Related]
27. Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine. Bromuro C; Torosantucci A; Chiani P; Conti S; Polonelli L; Cassone A Infect Immun; 2002 Oct; 70(10):5462-70. PubMed ID: 12228271 [TBL] [Abstract][Full Text] [Related]
28. Synthesis of 3,6-branched oligomannoside fragments of the mannan from Candida albicans cell wall corresponding to the antigenic factor 4. Karelin AA; Tsvetkov YE; Paulovicová L; Bystrický S; Paulovicová E; Nifantiev NE Carbohydr Res; 2010 Jul; 345(10):1283-90. PubMed ID: 20096401 [TBL] [Abstract][Full Text] [Related]
29. Specificity of the monoclonal antibody 3H8 in the immunohistochemical identification of Candida species. Järvensivu A; Rautemaa R; Sorsa T; Richardson M Oral Dis; 2006 Jul; 12(4):428-33. PubMed ID: 16792731 [TBL] [Abstract][Full Text] [Related]
30. Role of specific determinants in mannan of Candida albicans serotype A in adherence to human buccal epithelial cells. Miyakawa Y; Kuribayashi T; Kagaya K; Suzuki M; Nakase T; Fukazawa Y Infect Immun; 1992 Jun; 60(6):2493-9. PubMed ID: 1375200 [TBL] [Abstract][Full Text] [Related]
31. Differences in the antigenic expression of immunomodulatory mannoprotein constituents on yeast and mycelial forms of Candida albicans. Torosantucci A; Boccanera M; Casalinuovo I; Pellegrini G; Cassone A J Gen Microbiol; 1990 Jul; 136(7):1421-8. PubMed ID: 1700063 [TBL] [Abstract][Full Text] [Related]
32. Conformational analysis of β-1,2-linked mannobiose to mannoheptaose, specific antigen of pathogenic yeast Candida albicans. Shibata N; Okawa Y Chem Pharm Bull (Tokyo); 2010 Oct; 58(10):1386-90. PubMed ID: 20930409 [TBL] [Abstract][Full Text] [Related]
33. Synthesis of a Candida albicans tetrasaccharide spanning the β1,2-mannan phosphodiester α-mannan junction. Dang AT; Johnson MA; Bundle DR Org Biomol Chem; 2012 Oct; 10(41):8348-60. PubMed ID: 22996034 [TBL] [Abstract][Full Text] [Related]
34. A β-mannan trisaccharide conjugate vaccine aids clearance of Candida albicans in immunocompromised rabbits. Lipinski T; Wu X; Sadowska J; Kreiter E; Yasui Y; Cheriaparambil S; Rennie R; Bundle DR Vaccine; 2012 Sep; 30(44):6263-9. PubMed ID: 22902677 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and immunogenicity of a glycopolymer conjugate. Lipinski T; Kitov PI; Szpacenko A; Paszkiewicz E; Bundle DR Bioconjug Chem; 2011 Feb; 22(2):274-81. PubMed ID: 21186827 [TBL] [Abstract][Full Text] [Related]
36. Isolation and chemical and biological characterization of antigenic mutants of Candida albicans serotype A. Miyakawa Y; Kagaya K; Kuribayashi T; Suzuki M; Fukazawa Y Yeast; 1989 Apr; 5 Spec No():S225-9. PubMed ID: 2665356 [TBL] [Abstract][Full Text] [Related]
37. Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis. Han Y; Ulrich MA; Cutler JE J Infect Dis; 1999 Jun; 179(6):1477-84. PubMed ID: 10228070 [TBL] [Abstract][Full Text] [Related]
38. Immunoreactivity of neoglycolipids constructed from oligomannosidic residues of the Candida albicans cell wall. Faille C; Michalski JC; Strecker G; Mackenzie DW; Camus D; Poulain D Infect Immun; 1990 Nov; 58(11):3537-44. PubMed ID: 2228224 [TBL] [Abstract][Full Text] [Related]
39. Combination immunotherapy of MAb B6.1 with fluconazole augments therapeutic effect to disseminated candidiasis. Lee JH; Jang EC; Han Y Arch Pharm Res; 2011 Mar; 34(3):399-405. PubMed ID: 21547671 [TBL] [Abstract][Full Text] [Related]
40. Preparation of monoclonal antibodies reactive with beta-1,2-linked oligomannosyl residues in the phosphomannan-protein complex of Candida albicans NIH B-792 strain. Tojo M; Shibata N; Kobayashi M; Mikami T; Suzuki M; Suzuki S Clin Chem; 1988 Mar; 34(3):539-43. PubMed ID: 3280163 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]